skip to main content

Shingrix Pre-Immunosuppression Timing — SCE Infectious Diseases MCQ

Instant feedback + full explanation. One question, done properly.

ModerateTravel Medicine & VaccinationShingrix Pre-Immunosuppression TimingSCE Infectious Diseases

A 45-year-old woman with SLE on Belimumab and Hydroxychloroquine develops shingles. She is also taking Mycophenolate. She has well-controlled disease. Shingrix vaccination had been planned but not yet administered. What is the lesson?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Shingrix should be administered BEFORE starting immunosuppressive therapy whenever possible — vaccination during immunosuppression has reduced efficacy; this case represents a missed prevention opportunity

This is a teachable moment about preventive vaccination timing. Ideally, Shingrix should be administered BEFORE initiating immunosuppressive therapy (at least 2 weeks before, though even shortly before is better than after). If not possible pre-immunosuppression, Shingrix can still be given DURING immunosuppression — it is a recombinant (non-live) vaccine and safe — but efficacy may be reduced. BSR/BHIVA guidelines recommend assessing vaccination status and completing recommended vaccines before starting biologic/immunosuppressive therapy. This missed opportunity is unfortunately common in clinical practice.

Reference: BSR 2024 – Vaccination in immunosuppression; UKHSA 2024 – Green Book Ch 28a; NICE 2024